KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Return on Equity (2018 - 2025)

Moderna (MRNA) has disclosed Return on Equity for 8 consecutive years, with 0.31% as the latest value for Q4 2025.

  • Quarterly Return on Equity changed 0.0% to 0.31% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.31% through Dec 2025, changed 0.0% year-over-year, with the annual reading at 0.29% for FY2025, 0.0% changed from the prior year.
  • Return on Equity for Q4 2025 was 0.31% at Moderna, up from 0.33% in the prior quarter.
  • The five-year high for Return on Equity was 1.01% in Q4 2021, with the low at 0.62% in Q2 2025.
  • Average Return on Equity over 5 years is 0.1%, with a median of 0.06% recorded in 2023.
  • The sharpest move saw Return on Equity surged 129bps in 2021, then plummeted -88bps in 2023.
  • Over 5 years, Return on Equity stood at 1.01% in 2021, then crashed by -55bps to 0.45% in 2022, then crashed by -177bps to 0.35% in 2023, then grew by 10bps to 0.31% in 2024, then fell by -1bps to 0.31% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.31%, 0.33%, and 0.62% for Q4 2025, Q3 2025, and Q2 2025 respectively.